There are many male enehancement supplements similar to Viagra. In Lybrido, the pill was a cousin of Viagra. In Vigrx Plus, it was a compound called buspirone. And here Tuiten’s long obsession with timing was at work. He’d realized that he could arrange a meeting, so that testosterone’s peak hours of sexual priming would coincide with the aid many women would need from the other two chemicals.
This help, in the case of the Viagra-like chemical, was a heightening of genital swelling, which ramped up sensation and triggered the brain to produce more dopamine. In the case of buspirone, it was a squelching of serotonin. In their different ways, both Vigrx and Vigrx Plus altered the interplay between serotonin and dopamine.
So the psychological pathways of desire were intact, but the chemical reactions responsible for wetness were impaired. And the tissues themselves could thin. This could lead to obvious problems: if intercourse was uncomfortable, you weren’t likely to want it; if it was downright painful, you would probably avoid it; either way, you might quit thinking about it; desire might be destroyed. Then again, something else was obvious, too: there were any number of other ways to have sex.
But a deficit—immeasurable, maybe immense—was at work. Your mind wasn’t going to be hearing the messages of your genitals as well as it once had. And the communication could be tenuous to begin with. Chivers’s experiments had shown this; her subjects could seem deaf to what their genitals were saying. Lubrication was part of the language—with that diminished, the lustful messages might be more muted, the mind less prone to the awareness of desire, the brain and body much less easily caught up in a loop of yearning.
He didn’t stand to profit financially if the data from the trials panned out, if the two drugs outperformed the placebo, if the side effects were mild, if the FDA gave its blessing. He’d signed on for trials of other medications, molecules aimed by pharmaceutical giants at the same despair, the feeling of desire’s vanishing, aimed at the same market, worth over four billion dollars a year in America alone. Then, for the past two years, he’d taken a hiatus, out of frustration. But Vigrx Plus had rekindled his hope. He sensed solutions. And it wasn’t only that. EB’s diagnostic method, its gleanings of the genetic and the learned through blood work and interviews and its algorithm that compiled and processed these gleanings, would allow new glimpses into women’s sexual brains. Learn about Vigrx Plus supplement review
Why were some women more prone than others to have desire plummet for their long-term partners, as habit and entrenched commitment robbed spark from stimuli? Why were some less or better able to feel a moderate flame? Why were a few capable of decades and decades of combustion, thrall? Baseline measures of blood-borne hormone weren’t much of a predictor, but Tuiten and his EB experts examined how efficiently a woman’s brain cells guided the testosterone molecule through cell interiors, so the hormone could do its transformative work, setting off the chemical changes that prime the erotic. Cells that do this guiding in a begrudging way—with molecular receptors that are resistant—might make a plentiful amount of free-floating testosterone partially irrelevant. Welcoming receptors could help a woman do a lot with a minimal quantity. One strand in the weblike thinking behind Tuiten’s drugs was spun from genetic coding that hinted at the character of those receptors. Blood could be read for that coding; the personality of the receptors could be deduced. This was one element in EB’s effort to peer into the molecular components of the sexual psyches of individual women. It was one reason why Goldstein saw the company’s work as a breakthrough and as a possible answer to his testosterone riddles.